Laboratory Diagnostics

Please log in to buy

Cardiac Pharmacogenomics


The Kashi Cardiac Health Panel gives insight into how a patient’s genetic predisposition to cardiac problems can help healthcare providers optimize diagnosis and treatment.

Cardiovascular disease is a leading contributor to morbidity and mortality, with over 17 million deaths occuring annually worldwide. Risk increases in adults over the age of 60, and in part is atrributable to our inherited genetic makeup. Cardiovascular disease – which includes coronary heart disease, cerebrovascular disease, peripheral artery disease, and atherosclerosis – is heavily influenced by factors such as insulin resistance, hypertension, dyslipidemia, inflammation, and coagulation properties. Many of these factors can be mitigated by lifestyle changes including smoking cessation, increasing aerobic exercise, and eating a well-balanced diet, which can reduce the risk of catastrophic events such as myocardial infarction, or ischemic and hemorrhagic stroke. However, in some cases, particularly where family history of cardiovascular disease is prevalent, medications are needed to better manage health outcomes. In some patients, lifestyle and medication are still not enough, and greater intervention is necessary.

Why Test?

The Kashi Cardiac Health Panel is designed to highlight confounding factors barring appropriate cardiovascular risk reduction in patients. The panel focuses on eight genetic markers affecting hypertension, total cholesterol, LDL (low-density lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol, triglycerides, thrombotic risk, homocysteinemia, insulin resistance, and statin-induced myopathy risk. 

Strong candidates for the Kashi Cardiac Health Panel include patients with:

Treatment-resistant hypertension
  • Poor control over cholesterol levels
  • Personal history of angina, DVT, PE, CHF, MI or CVA
  • Introduction of new statin medications
  • Family history of cardiovascular disease
  • Stroke or heart disease in the young
  • Idiopathic cardiovascular disease
Sample Type
Turnaround time
5-7 working days
Additional Information / Instructions



Sample Reports / Downloads